Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Surgery in small cell lung cancer.

B L Graham1, L Balducci, T Khansur

  • 1Division of Medical Oncology and Thoracic Surgery, University of Mississippi Medical Center, Jackson.

The Annals of Thoracic Surgery
|June 1, 1988
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Estimated Blood Loss in Group O as Compared to Non-group O Radical Prostatectomy Patients.

Hematology (Amsterdam, Netherlands)·2016
Same author

Treating cancer and no-cancer pain in older and oldest old patients.

Current pharmaceutical design·2015
Same author

Treating cancer in older and oldest old patients.

Current pharmaceutical design·2015
Same author

Improvement of a rapid screening test for chronic granulomatous disease.

International journal of immunopathology and pharmacology·2013
Same author

Prevalence of aging population in the Middle East and its implications on cancer incidence and care.

Annals of oncology : official journal of the European Society for Medical Oncology·2013
Same author

Polypharmacy and the management of the older cancer patient.

Annals of oncology : official journal of the European Society for Medical Oncology·2013

Surgery for small cell lung cancer (SCLC) is being reconsidered due to improved survival rates. Early-stage SCLC patients show promising outcomes with resection, and chemotherapy may expand surgical candidacy.

Area of Science:

  • Oncology
  • Thoracic Surgery
  • Pulmonary Medicine

Background:

  • Surgery for small cell lung cancer (SCLC) was largely abandoned in the 1960s.
  • Recent studies suggest a potential role for surgical resection in select SCLC cases.

Purpose of the Study:

  • To reassess the role of surgery in the management of small cell lung cancer.
  • To evaluate survival outcomes and identify patient subsets who may benefit from surgical intervention.

Main Methods:

  • Review of prospective studies reporting survival data for SCLC patients undergoing surgical resection.
  • Analysis of survival rates across different disease stages (I, II, and III).
  • Consideration of neoadjuvant chemotherapy to increase surgical eligibility.

Related Experiment Videos

Main Results:

  • The Armed Forces Asymptomatic Pulmonary Nodule Study reported a 36% 5-year survival with surgery.
  • Five-year survival post-resection ranges from 22-83% for Stage I and 0-50% for Stages II/III SCLC.
  • Approximately 10% of SCLC patients may be candidates for surgery, with more becoming eligible after chemotherapy.

Conclusions:

  • Surgical resection is being cautiously reassessed for small cell lung cancer, particularly in early stages.
  • Optimal postoperative management includes combination chemotherapy and prophylactic cranial irradiation for complete resections.
  • Postoperative thoracic irradiation may benefit patients with mediastinal node involvement, and molecular biology insights could further refine treatment approaches.